他汀类药物使用与带状疱疹风险:英国临床实践研究数据链的巢式病例对照研究
BACKGROUND: Statins are commonly prescribed worldwide and recent evidence suggests that they may increase the risk of herpes zoster (HZ). OBJECTIVES: To quantify the effect of statin exposure on the risk of HZ in the U.K.…
核心结论
- 研究结果支持他汀治疗可能导致带状疱疹风险增加的假说。
研究设计与样本
- 采用匹配病例对照研究,数据来自英国初级保健和医院记录。
- 纳入18岁以上 incident 带状疱疹患者,按年龄、性别和全科诊所匹配最多4名对照。
- 他汀暴露定义为曾使用他汀,并记录最近一次处方的日剂量和距最近处方的时间。
- 主要结局为 incident 带状疱疹诊断,采用条件逻辑回归估计OR并调整潜在混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Statins are commonly prescribed worldwide and recent evidence suggests that they may increase the risk of herpes zoster (HZ). OBJECTIVES: To quantify the effect of statin exposure on the risk of HZ in the U.K. METHODS: A matched case-control study was conducted using data from U.K. primary care and hospital records. Patients > 18 years with an incident diagnosis of HZ were matched to up to four controls for age, sex and general practice. Patients were included in the statin exposure group if they had ever used a statin, and the daily dosage of the most recent statin prescription and the time since the most recent statin prescription were also recorded. The primary outcome was an incident diagnosis of HZ. Odds ratios (ORs) were estimated from conditional logistic regression and adjusted for potential confounders. RESULTS: A total of 144 959 incident cases of HZ were matched to 549 336 controls. Adjusted analysis suggested strong evidence for an increase in the risk of HZ related to statin exposure (OR 1·13, 95% confidence interval 1·11-1·15). There was also an increased risk when dosages were increased for patients who were currently or had recently been receiving statin treatment (Ptrend < 0·001), and we found an attenuation of the increased risk of HZ in previous statin users as the time since last statin exposure increased (Ptrend < 0·001). CONCLUSIONS: These findings are consistent with the hypothesis that statin therapy leads to an increase in the risk of HZ.
引用
- Matthews A, Turkson M, Forbes H, et al. Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the U.K. Clinical Research Practice Datalink. Br J Dermatol. 2016. PMID: 27292233. doi:10.1111/bjd.14815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。